Crescita Therapeutics Investor Relations Material
Latest events
Q4 2024
17 Mar, 2025
Q3 2024
5 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Crescita Therapeutics Inc
Access all reports
Crescita Therapeutics Inc. is a Canadian company engaged in the commercial dermatology sector. It specializes in both prescription and non-prescription skincare products aimed at treating various skin conditions and diseases. Crescita's product portfolio includes a notable prescription product, Pliaglis, which utilizes a proprietary phase-changing cream technology and is available in over 40 countries. The company is headquartered in Laval, Quebec, and its shares are listed on the Toronto Stock Exchange.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CTX
Country
🇨🇦 Canada